explore -WSS

explore

author：knowledge 2025-08-20 09:39:51 - browse：4

1:56Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Target has recalled another 2.2 million of its Threshold candles due to reports of candle jars breaking or cracking during use.

In May, the United States Consumer Product Safety Commission announced the recall of nearly 5 million Target Threshold candle products after the retailer received 137 reports of it breaking or cracking during use.

Now, the Minnesota-based retailer has recalled another 2.2 million candles, the CPC announced Thursday.

"Target received 19 reports of the candle jar breaking or cracking during use, resulting in one minor injury," the agency stated.

MORE: General Motors recalls over 600K cars due to car seat safety issue

Six injuries were reported in the previous recall, including lacerations and severe burns, according to the CPSC.

"This recall involves certain Threshold Glass Jar 5.5 ounce 1-Wick, 14 ounce 3-Wick and 20 ounce 3-Wick Candles in multiple scents," the CPSC stated. "The recalled item numbers are printed on the bottom of the glass jars."

PHOTO: Threshold Glass Jar Candles sold exclusively by Target. — Threshold Glass Jar Candles sold exclusively by Target.U.S. Consumer Product Safety Commission

Click here for a full list of the recalled product details and item numbers.

The CPSC urged consumers to stop using the recalled candles immediately and return them to Target for a refund. Customers can also contact Target for a prepaid return label to send them back by mail.

The candles, which were manufactured in Vietnam, were sold at Target stores nationwide as well as online from August 2019 through March 2023 for between $3 and $20.

An earlier version of this story was originally published May 19, 2023.

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Why Marc Tessier

WSS

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

New chief aims to remake Sanofi Genzyme

Reframing the conversation around gain

Pfizer's Covid pill remains 89% effective in final analysis, company says

Listen: BridgeBio's big week & Lilly's Alzheimer's data

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

focus

explore

MORE: General Motors recalls over 600K cars due to car seat safety issue

focus

Supreme Court strikes down use of affirmative action

Biden White House, tech companies launch new safeguards around emerging AI technology

Psychedelics group wrestles with new pharma identity

Meta looks to target Twitter with a rival app called Threads

Virginia high school admissions case could be legal follow

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

What does generative AI mean for health care? We asked experts

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

In age of alternative facts, a scholarly course on calling out crap

New case study details death in closely watched Alzhiemer's trial

leisure time

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

The biotech scorecard for the 2nd quarter: 12 industry events to watch

EMA weighs against approval for Mirati's lung cancer drug

Community addresses injustice for Long Island mothers

Did the public have the right to know Arthur Ashe had AIDS?

explore

leisure time

focus

focus